Tarsus Pharmaceuticals, Inc. - Common Stock (TARS)
CUSIP: 87650L103
Q4 2024 13F Holders as of 31 Dec 2024
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 42,450,857
- Total 13F shares
- 40,257,261
- Share change
- -3,048,720
- Total reported value
- $2,228,992,305
- Put/Call ratio
- 431%
- Price per share
- $55.37
- Number of holders
- 192
- Value change
- -$65,425,283
- Number of buys
- 106
- Number of sells
- 77
Quarterly Holders Quick Answers
What is CUSIP 87650L103?
CUSIP 87650L103 identifies TARS - Tarsus Pharmaceuticals, Inc. - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 87650L103:
Top shareholders of TARS - Tarsus Pharmaceuticals, Inc. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| BlackRock, Inc. |
13F
|
Company |
8.8%
|
3,755,504
|
$123,518,528 | — | 30 Sep 2024 | |
| RTW INVESTMENTS, LP |
13F
3/4/5
|
Company · 10%+ Owner |
8%
|
3,412,486
|
$112,236,665 | — | 30 Sep 2024 | |
| Cowen Financial Products LLC |
13D/G
|
— |
4.9%
|
1,909,228
|
$94,926,816 | $0 | 31 Dec 2024 | |
| Paradigm Biocapital Advisors LP |
13F
|
Company |
5.7%
|
2,440,445
|
$80,266,236 | — | 30 Sep 2024 | |
| TANG CAPITAL MANAGEMENT LLC |
13F
|
Company |
5.3%
|
2,254,797
|
$74,160,273 | — | 30 Sep 2024 | |
| MORGAN STANLEY |
13F
|
Company |
5.2%
|
2,208,588
|
$72,640,468 | — | 30 Sep 2024 | |
| COWEN AND COMPANY, LLC |
13F
|
Company |
5.2%
|
2,197,385
|
$72,271,992 | — | 30 Sep 2024 | |
| JENNISON ASSOCIATES LLC |
13F
|
Company |
5.1%
|
2,178,580
|
$71,653,498 | — | 30 Sep 2024 | |
| VANGUARD GROUP INC |
13F
|
Company |
4.9%
|
2,097,323
|
$68,980,953 | — | 30 Sep 2024 | |
| Frazier Life Sciences Management, L.P. |
13F
|
Company |
3.7%
|
1,587,527
|
$52,213,763 | — | 30 Sep 2024 | |
| Vivo Capital IX, LLC |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
2,469,001
|
$49,380,020 | — | 05 May 2022 | |
| PERCEPTIVE ADVISORS LLC |
13F
|
Company |
3.1%
|
1,296,416
|
$42,639,122 | — | 30 Sep 2024 | |
| Assenagon Asset Management S.A. |
13F
|
Company |
2.7%
|
1,141,247
|
$37,535,614 | — | 30 Sep 2024 | |
| Ikarian Capital, LLC |
13F
|
Company |
2.4%
|
1,030,277
|
$33,885,812 | — | 30 Sep 2024 | |
| STATE STREET CORP |
13F
|
Company |
2.1%
|
899,379
|
$29,580,575 | — | 30 Sep 2024 | |
| ExodusPoint Capital Management, LP |
13F
|
Company |
2.1%
|
883,043
|
$29,043,000 | — | 30 Sep 2024 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
2%
|
835,790
|
$27,494,430 | — | 30 Sep 2024 | |
| Artisan Partners Limited Partnership |
13F
|
Company |
1.7%
|
709,018
|
$23,319,602 | — | 30 Sep 2024 | |
| Invesco Ltd. |
13F
|
Company |
1.6%
|
682,097
|
$22,434,171 | — | 30 Sep 2024 | |
| Tetragon Partners GP Ltd |
13F
|
Company |
1.4%
|
614,117
|
$20,198,308 | — | 30 Sep 2024 | |
| MACQUARIE GROUP LTD |
13F
|
Company |
1.4%
|
594,878
|
$19,566,000 | — | 30 Sep 2024 | |
| LORD, ABBETT & CO. LLC |
13F
|
Company |
1.4%
|
594,876
|
$19,565,000 | — | 30 Sep 2024 | |
| Ensign Peak Advisors, Inc |
13F
|
Company |
1.4%
|
587,030
|
$19,307,416 | — | 30 Sep 2024 | |
| J. Goldman & Co LP |
13F
|
Company |
1.3%
|
557,500
|
$18,336,175 | — | 30 Sep 2024 | |
| Cormorant Asset Management, LP |
13F
|
Company |
1.2%
|
500,000
|
$16,445,000 | — | 30 Sep 2024 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
1%
|
440,167
|
$14,477,093 | — | 30 Sep 2024 | |
| Jefferies Financial Group Inc. |
13F
|
Company |
0.99%
|
420,758
|
$13,838,731 | — | 30 Sep 2024 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
0.95%
|
403,963
|
$13,285,860 | — | 30 Sep 2024 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.91%
|
384,467
|
$12,645,119 | — | 30 Sep 2024 | |
| Integral Health Asset Management, LLC |
13F
|
Company |
0.88%
|
375,000
|
$12,333,750 | — | 30 Sep 2024 | |
| Ghost Tree Capital, LLC |
13F
|
Company |
0.82%
|
350,000
|
$11,511,500 | — | 30 Sep 2024 | |
| HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND |
13F
|
Company |
0.8%
|
338,400
|
$11,129,976 | — | 30 Sep 2024 | |
| Ally Bridge Group (NY) LLC |
13F
|
Company |
0.76%
|
321,898
|
$10,587,225 | — | 30 Sep 2024 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.75%
|
317,555
|
$10,444,384 | — | 30 Sep 2024 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.7%
|
296,003
|
$9,735,539 | — | 30 Sep 2024 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.68%
|
290,009
|
$9,538,396 | — | 30 Sep 2024 | |
| BOOTHBAY FUND MANAGEMENT, LLC |
13F
|
Company |
0.65%
|
275,563
|
$9,063,267 | — | 30 Sep 2024 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.63%
|
268,775
|
$8,840,010 | — | 30 Sep 2024 | |
| TWO SIGMA ADVISERS, LP |
13F
|
Company |
0.6%
|
256,400
|
$8,432,996 | — | 30 Sep 2024 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
0.56%
|
239,315
|
$7,872,000 | — | 30 Sep 2024 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.55%
|
233,468
|
$7,678,764 | — | 30 Sep 2024 | |
| TCG Crossover Management, LLC |
13F
|
Company |
0.55%
|
231,820
|
$7,624,560 | — | 30 Sep 2024 | |
| Vestal Point Capital, LP |
13F
|
Company |
0.54%
|
230,000
|
$7,564,700 | — | 30 Sep 2024 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.52%
|
222,515
|
$7,318,518 | — | 30 Sep 2024 | |
| Allspring Global Investments Holdings, LLC |
13F
|
Company |
0.5%
|
210,531
|
$6,924,364 | — | 30 Sep 2024 | |
| AIGH Capital Management LLC |
13F
|
Company |
0.48%
|
204,413
|
$6,723,144 | — | 30 Sep 2024 | |
| Clearbridge Investments, LLC |
13F
|
Company |
0.45%
|
191,374
|
$6,294,288 | — | 30 Sep 2024 | |
| Schonfeld Strategic Advisors LLC |
13F
|
Company |
0.44%
|
187,513
|
$6,167,302 | — | 30 Sep 2024 | |
| D. E. Shaw & Co., Inc. |
13F
|
Company |
0.43%
|
182,095
|
$5,989,105 | — | 30 Sep 2024 | |
| Sands Capital Alternatives, LLC |
13F
|
Company |
0.4%
|
170,000
|
$5,591,300 | — | 30 Sep 2024 |
Institutional Holders of Tarsus Pharmaceuticals, Inc. - Common Stock (TARS) as of Q4 2024
As of 31 Dec 2024,
Tarsus Pharmaceuticals, Inc. - Common Stock (TARS) was held by
192 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
40,257,261 shares.
The largest 10 holders included
BlackRock, Inc., RTW INVESTMENTS, LP, Paradigm Biocapital Advisors LP, JENNISON ASSOCIATES LLC, TANG CAPITAL MANAGEMENT LLC, VANGUARD GROUP INC, MORGAN STANLEY, TORONTO DOMINION BANK, Frazier Life Sciences Management, L.P., and LORD, ABBETT & CO. LLC.
This page lists
194
institutional shareholders reporting positions in this security
for the Q4 2024 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q4 2024 vs Q3 2024 Across Filers
Q3 2024 holders
161
Q4 2024 holders
192
Holder diff
31
| Investor | Q3 2024 Shares | Q4 2024 Shares | Share Diff | Share Chg % | Q3 2024 Value $ | Q4 2024 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.